Report Detail

Biotechnology Cell Analysis Global Market – Forecast To 2025

  • RnM3776316
  • |
  • 12 March, 2020
  • |
  • Global
  • |
  • 660 Pages
  • |
  • IQ4I Research & Consultancy
  • |
  • Biotechnology

1 EXECUTIVE SUMMARY 31

    2 INTRODUCTION 42

    • 2.1 KEY TAKEAWAYS 42
    • 2.2 REPORT DESCRIPTION 43
    • 2.3 MARKETS COVERED 45
    • 2.4 STAKEHOLDERS 48
    • 2.5 RESEARCH METHODOLOGY 49
      • 2.5.1 MARKET SIZE ESTIMATION 50
      • 2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION 53
      • 2.5.3 SECONDARY SOURCES 54
      • 2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 55
      • 2.5.5 PRIMARY SOURCES 56
      • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 56
      • 2.5.7 ASSUMPTIONS 57

    3 MARKET ANALYSIS 58

    • 3.1 INTRODUCTION 58
    • 3.2 MARKET SEGMENTATION 59
    • 3.3 FACTORS INFLUENCING MARKET 61
      • 3.3.1 DRIVERS AND OPPORTUNITIES 62
        • 3.3.1.1 Rising incidence of life-threatening infectious diseases 62
        • 3.3.1.2 Increasing funding and investment in cell-based research 62
        • 3.3.1.3 Introduction of enhanced cell imaging system reduces the cost and time consumption for the drug discovery process 63
        • 3.3.1.4 Availability of advanced cell analysis instruments 64
        • 3.3.1.5 Increasing demand for cell analysis products by end-users 66
        • 3.3.1.6 Emergence of liquid biopsy tests using single cell analysis 67
        • 3.3.1.7 Emerging asia pacific cell analysis market 67
        • 3.3.1.8 Availability of cell analysis service providers 68
        • 3.3.1.9 Automation in oncology research for early diagnosis 69
      • 3.3.2 RESTRAINTS & THREATS 70
        • 3.3.2.1 Lack of skilled personnel to use advanced cell analysis instruments 70
        • 3.3.2.2 Expensive cell analysis instruments 70
        • 3.3.2.3 Maintaining consistency, reproducibility of assays and lack of standardization 71
        • 3.3.2.4 Stringent regulatory framework limits advancements in cellular analysis market 72
    • 3.4 REGULATORY AFFAIRS 72
      • 3.4.1 U.S. 72
      • 3.4.2 EUROPE 74
      • 3.4.3 CHINA 76
      • 3.4.4 INDIA 76
      • 3.4.5 JAPAN 77
    • 3.5 PORTER’S FIVE FORCE ANALYSIS 78
      • 3.5.1 THREAT OF NEW ENTRANTS 79
      • 3.5.2 THREAT OF SUBSTITUTES 79
      • 3.5.3 COMPETITIVE RIVALRY 79
      • 3.5.4 BARGAINING POWER OF SUPPLIERS 80
      • 3.5.5 BARGAINING POWER OF BUYERS 80
    • 3.6 LATEST AND UPCOMING PRODUCTS 81
    • 3.7 ONGOING RESEARCHES AND FUNDING SCENARIO 90
    • 3.8 SUPPLY CHAIN ANALYSIS 91
    • 3.9 MARKET SHARE ANALYSIS 96
      • 3.9.1 MARKET SHARE ANALYSIS BY CELL ANALYSIS MAJOR PLAYERS 96
      • 3.9.2 MARKET SHARE ANALYSIS BY SINGLE-CELL ANALYSIS MAJOR PLAYERS 99

    4 CELL ANALYSIS GLOBAL MARKET, BY TECHNIQUES 101

    • 4.1 INTRODUCTION 101
    • 4.2 MOLECULAR APPROACHES 105
      • 4.2.1 PCR (POLYMERASE CHAIN REACTION) 111
      • 4.2.2 SEQUENCING 115
      • 4.2.3 MICROFLUIDICS AND MICROARRAYS 121
      • 4.2.4 CELL ISOLATION AND SEPARATION 124
    • 4.3 IMAGE BASED APPROACHES 129
      • 4.3.1 MICROSCOPY 135
      • 4.3.2 CYTOMETRY 144
      • 4.3.3 HIGH CONTENT SCREENING 148
      • 4.3.4 SPECTROPHOTOMETRY 150

    5 CELL ANALYSIS GLOBAL MARKET, BY PRODUCTS 152

    • 5.1 INTRODUCTION 152
    • 5.2 CONSUMABLES 156
      • 5.2.1 ASSAY KITS 160
      • 5.2.2 REAGENTS 166
      • 5.2.3 MICROPLATES 168
      • 5.2.4 CELL CULTURE CONSUMABLES 170
      • 5.2.5 OTHERS 172
    • 5.3 INSTRUMENTS 174
      • 5.3.1 CELL COUNTERS 178
      • 5.3.2 CELL MICROARRAYS AND MICROFLUIDICS 183
      • 5.3.3 LIQUID HANDLING SYSTEMS 187
      • 5.3.4 CYTOMETERS 191
      • 5.3.5 HIGH CONTENT SCREENING SYSTEMS 196
      • 5.3.6 MICROPLATE READERS 199
      • 5.3.7 PCR INSTRUMENTS 202
      • 5.3.8 SEQUENCING INSTRUMENTS 206
      • 5.3.9 SPECTROPHOTOMETERS 210
      • 5.3.10 MICROSCOPES 214
      • 5.3.11 OTHER INSTRUMENTS 222
    • 5.4 SOFTWARE AND SERVICES 224

    6 CELL ANALYSIS GLOBAL MARKET, BY APPLICATION 227

    • 6.1 INTRODUCTION 227
    • 6.2 CELL ANALYSIS GLOBAL MARKET, BY PROCESS OF APPLICATION 229
      • 6.2.1 CELLULAR PROCESSES 231
      • 6.2.2 SIGNAL TRANSDUCTION PATHWAY 234
      • 6.2.3 CIRCULATING TUMOR CELLS 236
      • 6.2.4 SINGLE-CELL ANALYSIS 239
      • 6.2.5 EPIGENETIC TARGET ANALYSIS 244
      • 6.2.6 SUBPOPULATION CHARACTERIZATION 246
      • 6.2.7 DRUG AND CANDIDATE SCREENING 248
    • 6.3 CELL ANALYSIS GLOBAL MARKET, BY FIELD OF APPLICATION 250
      • 6.3.1 FORENSICS 253
      • 6.3.2 THERAPEUTICS 255
      • 6.3.3 GENOMIC ANALYSIS 257
      • 6.3.4 STEM CELL ANALYSIS 259
      • 6.3.5 BIOMARKER RESEARCH 261
      • 6.3.6 CELL IMAGING 263
        • 6.3.6.1 LIVE-CELL IMAGING 265
      • 6.3.7 DIAGNOSTICS 268
    • 6.4 CELL ANALYSIS GLOBAL MARKET, BY THERAPEUTIC

    AREA OF APPLICATIONS 270

    • 6.4.1 CANCER RESEARCH 273
    • 6.4.2 GENETIC TESTING 275
    • 6.4.3 INFECTIOUS DISEASES 278
    • 6.4.4 IMMUNOLOGY 280
    • 6.4.5 OTHERS 282

    7 CELL ANALYSIS GLOBAL MARKET, BY END-USERS 284

    • 7.1 INTRODUCTION 284
    • 7.2 HOSPITALS 287
    • 7.3 ACADEMIC & RESEARCH LABORATORIES 289
    • 7.4 DIAGNOSTIC LABORATORIES 291
    • 7.5 PHARMACEUTICALS AND BIOTECH COMPANIES 293
    • 7.6 CONTRACT RESEARCH ORGANISATIONS 295
    • 7.7 CELL BANKS 297
    • 7.8 OTHERS 299

    8 REGIONAL MARKET ANALYSIS 301

    • 8.1 INTRODUCTION 301
    • 8.2 NORTH AMERICA 305
      • 8.2.1 UNITED STATES OF AMERICA 330
      • 8.2.2 REST OF NORTH AMERICA 339
    • 8.3 EUROPE 347
      • 8.3.1 GERMANY 372
      • 8.3.2 UNITED KINGDOM 380
      • 8.3.3 FRANCE 388
      • 8.3.4 REST OF EUROPE 396
    • 8.4 ASIA PACIFIC 404
      • 8.4.1 CHINA 429
      • 8.4.2 JAPAN 437
      • 8.4.3 INDIA 445
      • 8.4.4 REST OF APAC 453
    • 8.5 REST OF THE WORLD 461
      • 8.5.1 BRAZIL 486
      • 8.5.2 REST OF LATIN AMERICA 494
      • 8.5.3 MIDDLE EAST AND AFRICA 502

    9 COMPANY DEVELOPMENTS 510

    • 9.1 INTRODUCTION 510
      • 9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF CELL ANALYSIS MARKET PLAYERS 511
    • 9.2 NEW PRODUCT LAUNCH 512
    • 9.3 AGREEMENTS, PARTNER SHIPS AND COLLABORATIONS 518
    • 9.4 ACQUISITIONS 522
    • 9.5 APPROVAL 525
    • 9.6 BUSINESS EXPANSION 527

    10 MAJOR PLAYER PROFILES 529

    • 10.1 AGILENT TECHNOLOGIES, INC. 529
      • 10.1.1 OVERVIEW 529
      • 10.1.2 FINANCIALS 530
      • 10.1.3 PRODUCT PORTFOLIO 533
      • 10.1.4 KEY DEVELOPMENTS 538
      • 10.1.5 BUSINESS STRATEGY 540
      • 10.1.6 SWOT ANALYSIS 541
    • 10.2 BECTON DICKINSON AND COMPANY 542
      • 10.2.1 OVERVIEW 542
      • 10.2.2 FINANCIALS 543
      • 10.2.3 PRODUCT PORTFOLIO 547
      • 10.2.4 KEY DEVELOPMENTS 549
      • 10.2.5 BUSINESS STRATEGY 550
      • 10.2.6 SWOT ANALYSIS 551
    • 10.3 BIO-RAD LABORATORIES INC. 552
      • 10.3.1 OVERVIEW 552
      • 10.3.2 FINANCIALS 553
      • 10.3.3 PRODUCT PORTFOLIO 556
      • 10.3.4 KEY DEVELOPMENTS 559
      • 10.3.5 BUSINESS STRATEGY 559
      • 10.3.6 SWOT ANALYSIS 560
    • 10.4 DANAHER CORPORATION 561
      • 10.4.1 OVERVIEW 561
      • 10.4.2 FINANCIALS 562
      • 10.4.3 PRODUCT PORTFOLIO 565
      • 10.4.4 KEY DEVELOPMENTS 572
      • 10.4.5 BUSINESS STRATEGY. 572
      • 10.4.6 SWOT ANALYSIS 573
    • 10.5 GE HEALTHCARE 574
      • 10.5.1 OVERVIEW 574
      • 10.5.2 FINANCIALS 575
      • 10.5.3 PRODUCT PORTFOLIO 579
      • 10.5.4 KEY DEVELOPMENTS 583
      • 10.5.5 BUSINESS STRATEGY 584
      • 10.5.6 SWOT ANALYSIS 585
    • 10.6 ILLUMINA INC. 586
      • 10.6.1 OVERVIEW 586
      • 10.6.2 FINANCIALS 587
      • 10.6.3 PRODUCT PORTFOLIO 590
      • 10.6.4 KEY DEVELOPMENTS 591
      • 10.6.5 BUSINESS STRATEGY 594
      • 10.6.6 SWOT ANALYSIS 595
    • 10.7 MERCK KGAA 596
      • 10.7.1 OVERVIEW 596
      • 10.7.2 FINANCIALS 597
      • 10.7.3 PRODUCT PORTFOLIO 600
      • 10.7.4 KEY DEVELOPMENTS 603
      • 10.7.5 BUSINESS STRATEGY 604
      • 10.7.6 SWOT ANALYSIS 605
    • 10.8 OLYMPUS CORPORATION 606
      • 10.8.1 OVERVIEW 606
      • 10.8.2 FINANCIALS 607
      • 10.8.3 PRODUCT PORTFOLIO 610
      • 10.8.4 KEY DEVELOPMENTS 612
      • 10.8.5 BUSINESS STRATEGY 613
      • 10.8.6 SWOT ANALYSIS 614
    • 10.9 PERKINELMER, INC. 615
      • 10.9.1 OVERVIEW 615
      • 10.9.2 FINANCIALS 616
      • 10.9.3 PRODUCT PORTFOLIO 619
      • 10.9.4 KEY DEVELOPMENTS 622
      • 10.9.5 BUSINESS STRATEGY 623
      • 10.9.6 SWOT ANALYSIS 624
    • 10.10 PROMEGA CORPORATION 625
      • 10.10.1 OVERVIEW 625
      • 10.10.2 FINANCIALS 626
      • 10.10.3 PRODUCT PORTFOLIO 626
      • 10.10.4 KEY DEVELOPMENTS 630
      • 10.10.5 BUSINESS STRATEGY 631
      • 10.10.6 SWOT ANALYSIS 632
    • 10.11 QIAGEN N V 633
      • 10.11.1 OVERVIEW 633
      • 10.11.2 FINANCIALS 634
      • 10.11.3 PRODUCT PORTFOLIO 637
      • 10.11.4 KEY DEVELOPMENTS 644
      • 10.11.5 BUSINESS STRATEGY 646
      • 10.11.6 SWOT ANALYSIS 647
    • 10.12 THERMOFISHER SCIENTIFIC INC. 648
      • 10.12.1 OVERVIEW 648
      • 10.12.2 FINANCIALS 649
      • 10.12.3 PRODUCT PORTFOLIO 652
      • 10.12.4 KEY DEVELOPMENTS 656
      • 10.12.5 BUSINESS STRATEGY 658

    Cells are the biological units that are used for the identification and mapping of the basic biochemical and physical processes of life. Analysis of these cells plays a major role in gene identification, protein identification, transcription analysis and epigenomics at the cellular level by revealing the heterogeneity of the cells. Hospitals, academic institutions, government institutes, as well as pharmaceutical and biotechnology firms are increasing their focus on the application of cell analysis as an important tool in research, drug discovery and diagnosis. According to IQ4I analysis, the cell analysis global market is expected to reach $39,322.3 million by 2025 growing at a high single digit CAGR from 2018 to 2025.
    The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into molecular approaches and image-based approach where the molecular approach commanded the largest market and is expected to grow at a high single digit CAGR.
    The molecular approaches include the PCR, sequencing techniques, microarray and microfluidics, cell isolation and separation techniques performed at cells genomic level. Among molecular approaches PCR accounted for the largest share in 2018. The image-based approach is segmented into microscopy, cytometry, high content screening, and Spectrophotometers. Among image-based approaches Cytometry generated the largest revenue in 2018.
    The cell analysis products market is mainly segmented into consumables, instruments, software and services. The consumables include reagents, assay kits, microplates, cell culture consumables and others. Among these consumables commanded the largest market in 2018. The instrument segment comprises of cell counters, Cell microarray and microfluidics, liquid handling systems, cytometers, microfluidic devices, high content screening (HCS) systems microplate readers, PCR devices, sequencing instruments, spectrophotometer, microscopes and others. Among instruments, The PCR instruments commanded the largest share in 2018.Sequencing is expected to grow at a high single digit CAGR from 2018 to 2025 due to increasing adoption of sequencing technology in various life science research areas and decreasing cost of genome sequencing.
    By application, the market is categorized by processes, by field, and by therapeutic area. In the process of application, market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single-cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening. Cellular process application accounted for the largest revenue in 2018 and the Circulating tumor cell analysis market is expected to boom at double digit CAGR from 2018 to 2025. By field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics held the largest revenue in 2018 and stem cell analysis is expected to grow at a double digit CAGR from 2018 to 2025. The cell imaging market is further segmented into live-cell imaging which is expected to grow at high single digit CAGR. By therapeutic area, the market is further segmented into cancer research, infectious disease diagnosis, genetic testing, immunology, and others. The Cancer research accounted for the largest revenue in 2018.
    The end-users, the market is segmented into hospitals, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, diagnostic laboratories and others. Academic and research institutes generated the largest in 2018, but the Contract Research Organizations are expected to grow at double digit CAGR from 2018 to 2025.By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America held the largest market share in 2018, followed by Europe and Asia. The APAC regions tend to be market with opportunity for growth and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies have resulted in a growth of Asian markets. The rising incidence of life-threatening infectious diseases, increasing funding and investments in cell-based research from government and corporate, availability of advanced cell imaging and analysis systems that reduce the cost and time for drug discovery, availability of advanced cell analysis instruments, high demand for cell analysis products by end-users, emerging Asia-Pacific market, emerging cell analysis service providers and introduction of automation technologies in cancer research are driving the cell analysis market growth. However, stringent government regulations and patent-related issues, lack of skilled personnel to perform advanced cell analysis Instruments, and the high cost of some of the commercial instruments are expected to hamper the market growth.
    The cell analysis global market is competitive and all the players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions.
    The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
    • North America (U.S. and Rest of North America)
    • Europe (Germany, U.K. France and Rest of Europe)
    • Asia-Pacific (China, Japan, India and Rest of APAC)
    • Rest of the World ( Brazil, Rest of LATAM and Middle East and Others)


    Summary:
    Get latest Market Research Reports on Cell Analysis. Industry analysis & Market Report on Cell Analysis is a syndicated market report, published as Cell Analysis Global Market – Forecast To 2025. It is complete Research Study and Industry Analysis of Cell Analysis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,950.00
    $6,750.00
    $9,000.00
    3,787.55
    5,164.84
    6,886.45
    4,178.35
    5,697.76
    7,597.01
    518,383.80
    706,887.00
    942,516.00
    364,595.71
    497,175.98
    662,901.30
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report